Search Results - "Bergamaschini, L"

Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course by Castelli, R., Lambertenghi Delilliers, G., Gidaro, A., Cicardi, M., Bergamaschini, L.

“…Summary Immune thrombocytopenic purpura (ITP) is an autoimmune thrombocytopenia with shortened platelet survival and relative bone marrow failure. The…”
Get full text

Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration by Galimberti, D., Venturelli, E., Fenoglio, C., Guidi, I., Villa, C., Bergamaschini, L., Cortini, F., Scalabrini, D., Baron, P., Vergani, C., Bresolin, N., Scarpini, E.

“…Cerebrospinal fluid (CSF) levels of interleukin (IL)-6, IL-11 and leukaemia inhibitory factor (LIF) were evaluated in 43 patients with Alzheimer's disease (AD)…”
Get full text

Neuroprotection by Complement (C1) Inhibitor in Mouse Transient Brain Ischemia by De Simoni, M. G., Storini, C., Barba, M., Catapano, L., Arabia, A. M., Rossi, E., Bergamaschini, L.

“…The authors investigated the effect of the C1 inhibitor (C1-INH), the only known inhibitor of complement C1, in a murine model of transient focal ischemia…”
Get full text

Pin1 contribution to Alzheimer's disease: transcriptional and epigenetic mechanisms in patients with late-onset Alzheimer's disease by Arosio, B, Bulbarelli, A, Bastias Candia, S, Lonati, E, Mastronardi, L, Romualdi, P, Candeletti, S, Gussago, C, Galimberti, D, Scarpini, E, Dell'Osso, B, Altamura, C, MacCarrone, M, Bergamaschini, L, D'Addario, C, Mari, D

“…Neurofibrillary tangles and senile plaques are hallmarks of Alzheimer's disease (AD) although the molecular basis of their coexistence remains elusive. The…”
Get more information

Vasomotor reactivity in mild cognitive impairment—A study with transcranial Doppler sonography by Mosca, G, Zanetti, M, Abbate, C, Casè, A, Castelli, M, Vergani, C, Bergamaschini, L

Get full text

P.2.f.002 Selective DNA methylation of BDNF promoter in bipolar disorder by D'Addario, C, Dell'Osso, B, Galimberti, D, Scarpini, E, Arosio, B, Bergamaschini, L, Fenoglio, C, Candeletti, S, Romualdi, P, Altamura, A.C

Get full text

P01-199 - Selective DNA methylation of BDNF promoter and nociceptin gene in bipolar disorder by dell’Osso, B, d’Addario, C, Palazzo, M, Cattaneo, E, Galimberti, D, Scarpini, E, Bresolin, N, Arosio, B, Bergamaschini, L, Candeletti, S, Romualdi, P, Altamura, A.C

“…Introduction The etiology of bipolar disorder (BD) is still poorly understood and it has been proposed that altered expression of multiple mRNAs, affecting…”
Get full text

Endothelial targeting with C1‐inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver by Bergamaschini, L., Gobbo, G., Gatti, S., Caccamo, L., Prato, P., Maggioni, M., Braidotti, P., Di Stefano, R., Fassati, L. R.

“…Tissue damage during cold storage and reperfusion remains a major obstacle to wider use of transplantation. Vascular endothelial cells and complement…”
Get full text

PULMONARY EMBOLISM IN ELDERLY by Castelli, R, Bergamaschini, L, Porro, F, Pantaleo, G, Guariglia, A

Get full text

THE CONTRIBUTION OF CEREBRO-VASCULAR PATHOLOGY TO THE PATTERN OF COGNITIVE FUNCTIONING IN ELDERLY WITH MILD COGNITIVE IMPAIRMENT (MCI) by Bergamaschini, L, Mosca, G, Zanetti, M, Abbate, C, Casè, A, Bilotta, C, Vergani, C

Get full text

P.05.12 MANAGEMENT OF CHRONIC CONSTIPATION IN GERIATRIC PATIENTS: FIVE YEARS PROSPECTIVE STUDY by Neri, M.C., Antoniotti, N., Tassi, A.P., Bergamaschini, L.

Get full text

Substitution of a Single Amino Acid (Aspartic Acid for Histidine) Converts the Functional Activity of Human Complement C4B to C4A by Carroll, Michael C., Fathallah, Dehmanhi M., Bergamaschini, Luigi, Alicot, Elizabeth M., Isenman, David E.

“…The C4B isotype of the fourth component of human complement (C4) displays 3- to 4-fold greater hemolytic activity than does its other isotype C4A. This…”
Get full text

Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia by DE SIMONI, M. G, STORINI, C, BARBA, M, CATAPANO, L, ARABIA, A. M, ROSSI, E, BERGAMASCHINI, L

“…The authors investigated the effect of the C1 inhibitor (C1-INH), the only known inhibitor of complement C1, in a murine model of transient focal ischemia…”
Get full text

C1-inhibitor protects human endothelial cell metabolic activity from prolonged cold storage by Di Stefano, R, De Santis, M, Bergamaschini, L, Gobbo, G, Mosca, F

Get full text

C1 inhibitor potentiates the protective effect of organ preservation solution on endothelial cells during cold storage by Bergamaschini, L, Gatti, S, Caccamo, L, Prato, P, Latham, L, Trezza, P, Maggioni, M, Gobbo, G, Fassati, L.R

Get full text

Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes by Bergamaschini, L, Santangelo, T, Faricciotti, A, Ciavarella, N, Mannucci, PM, Agostoni, A

“…The role of Ig classes and subclasses in complement activation has been investigated both in vitro and in experimental animals, but not in humans. This study…”
Get full text

Consumption of C4b‐binding protein (C4BP) during in vivo activation of the classical complement pathway by BERGAMASCHINI, L., MIEDICO, A., CICARDI, M., COPPOLA, R., FAIONI, E. N., AGOSTONI, A.

“…C4BP has a central role in regulating the classical complement (C′) pathway, but it is still uncertain whether or not it is consumed during in vivo complement…”
Get full text

Mild Cognitive Impairment Subtypes and Vascular Dementia in Community-Dwelling Elderly People: A 3-Year Follow-Up Study by Zanetti, Mariella, Ballabio, Claudia, Abbate, Carlo, Cutaia, Chiara, Vergani, Carlo, Bergamaschini, Luigi

“…OBJECTIVES: To investigate whether mild cognitive impairment (MCI) with multiple impaired cognitive domains (mcd‐MCI) is a prodromal manifestation of vascular…”
Get full text

Localization of the human complement component C3 binding site on the IgG heavy chain by SHOHET, J. M, BERGAMASCHINI, L, DAVIS, A. E, CARROLL, M. C

“…The location of the covalent binding site of the third component of complement (C3) on the IgG heavy chain was determined by sequence analysis of peptides…”
Get full text

Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease by Bergamaschini, Luigi, Rossi, Emanuela, Storini, Claudio, Pizzimenti, Simone, Distaso, Maria, Perego, Carlo, De Luigi, Ada, Vergani, Carlo, De Simoni, Maria Grazia

“…We investigated the effect of long-term, peripheral treatment with enoxaparin, a low molecular weight heparin, in transgenic mice overexpressing human amyloid…”
Get full text